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Abstract
Background: The short form of the Borderline Symptom List (BSL-23) is a self-rating instrument used to assess specific
symptoms of borderline personality disorder (BPD). The original German version has shown good psychometric
proprieties. The BSL-23 can also be used to measure the effects of therapy on patients with BPD. The aim of this study
was to assess the psychometric properties of the French version of the BSL-23.
Methods: The French version of the BSL-23 was given to 265 subjects with BPD. Factor structure, reliability, test-retest
stability, convergent validity, divergent validity, and sensitivity to change were analysed. Forty-five subjects suffering
from attention-deficit hyperactivity disorder (ADHD) were used as controls to evaluate the specificity of BSL-23.
Results: A one-factor structure was obtained in the French version of the BSL-23, showing high internal consistency
(Cronbach’s alpha = .94) and test-retest reliability (r = .841). The French version of the BSL-23 was highly correlated
with depression severity, hopelessness, anger, motor impulsiveness, and BPD diagnosis. It was an efficient tool to
discriminate between BPD patients and ADHD patients, and showed good sensitivity to change in a group of BPD
patients who took part in a one-month DBT intervention.
Conclusions: The French version of the BSL-23 shows similar psychometric properties as the original German version.
This study therefore provides clinicians and researchers with a French instrument to measure BPD symptomatology.
Keywords: Borderline personality disorder, Dialectical Behavior Therapy, Self-report questionnaire, Emotional lability,
Impulsivity
Background
Borderline personality disorder (BPD) is characterized by
emotional dysregulation, impulsivity, self-damaging and
suicidal behaviours, interpersonal difficulties, and
identity disturbance. The lifetime prevalence of BPD
among the general population varies according to
surveys, diagnostic instruments and rules, but it is
estimated to be in between 0.7% and 2.7% in recent
studies [1–3]. BPD is a severe condition that causes
major impairments in a variety of contexts and is associ-
ated with poor socio-economic and familial outcomes
[4]. BPD patients are frequent users of mental health
services and their mortality rate by suicide reaches 10%
[5]. The relevance of early diagnosis has been demon-
strated by Kaess et al. [6], who showed that BPD can be
identified during adolescence.
In order to establish a diagnosis for BPD based on the
DSM-5 criteria [7], clinicians and researchers commonly
use structured interviews, such as the Structured Clin-
ical Interview for DSM-5 Axis II Personality Disorders
(SCID-II) [8]. In addition to the interviews, clinician-rated
scales, such as the Zanarini Rating Scale for Borderline
Personality Disorder [9] and the Borderline Personality
Disorder Severity Index [10], are used as screening tools
for BPD symptomatology or as instruments assessing
changes in the severity of the disorder. Finally, self-report
scales have been developed to take into account the
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subjective view patients have of their disorder. These scales
include, but are not limited to, the Borderline Evaluation of
Severity over Time [11] and the Borderline Symptom List
(BSL) [12, 13], both quantifying borderline-specific
symptomatology.
The initial BSL [12, 13] included 95 items based on
the criteria of the DSM-4, the Diagnostic Interview for
Borderlines-Revised (DIB-R) [14], and the opinions of
clinical experts and BPD patients. Each item describes a
complaint frequently made by BPD patients, such as “I
was lonely” or “I experienced stressful inner tension”. The
patients are asked to evaluate the intensity of each com-
plaint over the previous week on a 5-point Likert scale,
ranging from 0 (none) to 4 (very strong). The BSL-95
showed good psychometric properties [13]. No particu-
lar effect of gender, age or level of education was found.
Based on the 95-item scale in German, a shorter, 23-
item version of the BSL was developed [15, 16]. The
BSL-23 was validated on different samples representing
a total of 659 BPD patients. The psychometric properties
of the BSL-23 were similar to those of the BSL-95 and
the correlation between the two versions of the scale
was high (range: 0.958–0.963 in five different samples).
The factor analysis showed a one-factor structure, and
the internal consistency of the BSL-23, as well as its
test-retest reliability, were more than satisfactory
(Cronbach’s alpha: 0.935–0.969 and r = 0.82; p < 0.0001).
Furthermore, the BSL-23 discriminated BPD patients
from healthy subjects and from patients suffering from
other psychiatric disorders. It showed a positive correl-
ation with measures of psychopathology, depression and
anxiety, and a negative correlation with a measure of
global well-being. Finally, the BSL-23 was sensitive to
change [15, 16] after three months of dialectical behavior
therapy (DBT) [17]. The BSL-23 was also translated and
validated in Spanish. The Spanish BSL-23 [18] replicated
the one-factor structure of the original version and was
found to be a reliable and valid instrument for assessing
BPD severity and sensitivity to change. Moreover, it also
correlated with depressive symptomatology, state and
trait anxiety, hostility and impulsivity scores.
Only a few validated instruments are available in
French to specifically assess the severity of BPD symp-
tomatology, and to our knowledge there are no validated
self-report scales currently available. The BSL-23 is a
brief, sensitive, easy to use and specific instrument,
which can be repeated to assess changes in the severity
of the disorder over time. Our aim was to examine the
structure and psychometric properties of a French
version of the BSL-23 on a sample of BPD patients.
Factor structure, internal consistency, and test-retest
reliability were assessed. Correlations between the
French BSL-23 and other psychiatric symptoms were
explored. Furthermore, the instrument’s relevance in
discriminating BPD patients from a sample of patients
suffering from attention deficit and hyperactive dis-
order (ADHD) was also examined. Finally, sensitivity
to change after a four-week Intensive DBT (I-DBT)
[19, 20] was tested on a sample of 92 BPD patients.
Methods
Participants
BPD patients were recruited in two specialized out-
patient units (Geneva and Fribourg) treating patients
suffering from BPD and/or ADHD and relying on DBT
as a first-line treatment. Patients were interviewed by
general practitioners or psychiatrists to assess emotion
dysregulation, impulsive behaviours, self-damaging be-
haviours, and/or suspicion of BPD. Each patient was
interviewed first by a trained psychiatrist or psychologist,
and then assessed for psychiatric disorders with the
Diagnostic Interview for Genetic Studies (DIGS) [21], as
part of a broader study investigating genetic and epigen-
etic correlates of BPD [22]. BPD was assessed with the
BPD part of the SCID-II [8]. Only subjects filling the
criteria for BPD (5 or more DSM-5 criteria) were in-
cluded in the study. Psychotic disorder, bipolar
affective disorder type 1, and pervasive developmental
disorder were used as exclusion criteria. In order to
test sensitivity to change of the BSL-23, 92 BPD
patients were reassessed after a four-week I-DBT
program [19, 20]. I-DBT is an original adaptation of
DBT skills training which combines, in a short and
intensive format, individual sessions with the primary
therapist and skills-training groups based on the trad-
itional DBT modules: mindfulness, interpersonal effective-
ness, emotion regulation, and distress tolerance. Patients
are also offered telephone assistance with therapists
between 9 am and 6 pm. All therapists attend weekly meet-
ings with the consultation team.
Forty-five patients suffering from ADHD were also
recruited in order to test the discriminant validity of
BSL-23. The ADHD diagnosis was based on a clinical
evaluation by a trained psychiatrist and on the Diagnostic
Interview for ADHD in adults (DIVA 2.0) [23]. In
addition, patients completed the following questionnaires:
the Adult ADHD Self-Report Scale (ASRS v1.1) [24],
which assesses severity of adult ADHD, and the Wender
Utah Rating Scale (WURS) [25, 26], featuring a subset of
25 questions on a five point Likert-scale. Following Fossati
et al. [27], we used a very stringent cut-off score of 46 to
indicate the existence of ADHD in childhood. BPD was
clinically excluded by the same clinicians.
Assessment
At admission, each patient completed the following
self-report scales:
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The borderline symptom list (BSL-23)
Each subject completed the French version of the BSL-23
to assess BPD symptomatology. BSL-23 [15, 16] was
translated from English to French by NP and PP and an
independent English-speaking translator back-translated
the French version into English. In its original form, the
BSL-23 is a 23-item self-rated scale presenting a one-
factor structure and high internal consistency (Cronbach’s
alpha = .935). The original BSL-23 also boasts good reli-
ability for BPD diagnosis and discriminates BPD patients
from other psychiatric patients (mean effect size =1.13). It
has also shown a sensitivity to change through therapy.
Other self-report measurements
The Beck Depression Inventory II (BDI-II) [28] assesses
the current severity of depression symptoms. It includes
21 items that are rated on a four-point scale (0 to 3),
with scores ranging from 0 to 63. High scores indicate
greater severity.
The Beck Hopelessness Scale (BHS) [29] was used to
estimate the degree of pessimism and negativity about
the future. Featuring 20 true–false statements, the scores
of the scale range from 0 to 20. High scores indicate a
greater sense of hopelessness.
The Barrat Impulsivity Scale (BIS-10) [30] is a measure of
impulsiveness that includes 34 items rated on a four-point
scale (rarely/never, occasionally, often, almost always/
always. The scoring of the items reveal three factors:
motor impulsivity, cognitive impulsivity, and non-
planning impulsivity. High scores indicate a greater
level of impulsiveness.
The State-Trait Anger Expression Inventory (STAXI)
[31] is a 44-item self-report measure of the experience
and expression of anger. Items are rated on a four-point
frequency scale and scores range from 0 to 132. Five
subscales are calculated: state anger, trait anger, anger-in,
anger-out, and anger control, which assesses the inten-
sity of the angry feelings or the frequency at which anger
is experienced, expressed, or controlled.
The demographic data (Table 1) were obtained from a
standard questionnaire given to all participants. The
study was approved by the ethics committees of
Fribourg and of the Geneva University Hospital. Patients
signed an informed written consent form.
Statistical analysis
Data analysis was carried out using SPSS version 22 and
STATA release 13. Descriptive statistics were used to
describe the demographic and clinical characteristics of
the sample. To test internal consistency, a global
Cronbach’s alpha was estimated and the split-half
method was applied. In addition, Cronbach’s alphas were
estimated, with each of the 23 items removed one-by-
one from the scale. Test-retest reliability was evaluated
by paired-sample correlations.
To measure the appropriateness of the factor analysis,
the Kaiser-Meyer-Olkin (KMO) measure of sampling
adequacy and the Bartlett’s test of sphericity were used.
An exploratory factorial analysis (EFA) of principal
components with a Promax rotation was performed to
examine the factorial structure of the scale. A confirma-
tory factor analysis (CFA) was then performed to test
the adequacy of the one-factor model proposed by
Bohus et al. [16]. The accuracy of the fit with the ori-
ginal version of BSL-23 was tested with chi-squares; as
chi-squares are dependent on sample size, other indexes
recommended by Hu and Bentler [32] were also used:
the standardized root mean square residual (SRMR) and
the root mean square error of approximation (RMSEA).
Schermelleh-Engel et al. [33] consider that an RMSEA
between 0 and .05 indicates a good fit, whereas an
RMSEA between .05 and .08 is considered an acceptable
fit, and values between .08 and .10 are considered as a
mediocre fit. Values > .10 are not acceptable. The SRMR
should be less than .05 for a good fit [32], whereas values
smaller than .10 are still deemed acceptable. The com-
parative fit index (CFI) and the goodness of fit index
(GFI) were also used to test how well the model fits the
data. A CFI or GFI value over .90 generally indicates a
reasonable fit between the model and the data but Hu
and Bentler [32] recommend the use of a more severe
criterion (≥.95) to describe a good fit. Correlations be-
tween BSL-23 and other psychological scales (BDI-II,
Table 1 Clinical characteristics (N = 265)
Mean SD
Age 32.2 8.9
Education (years) 13.8 2.4
N %
Gender Women 239 90.2
Marital status Single 186 70.2
In couple 55 20.8
Divorced or widowed 24 9.1
Children 0 194 73.2
1 41 15.5
2 24 9.1
3 or more 6 2.3
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BHS, BIS-10 and STAXI) were analysed, using the
Bonferroni correction for multiple correlations. Correl-
ation for ordinal data (Spearman’s rho) was performed
to assess the association between BSL-23 and number of
BPD criteria in the SCID-II [8]. Discriminant validity
with a group of patients suffering from ADHD and no
co-occurring BPD was also tested.
Finally, in order to assess BSL-23 sensitivity to change
through therapy, scores before and after a four-week
I-DBT [19, 20] were compared. The change of the
BSL-23 scores before and after I-DBT was evaluated
by paired-sample t-tests and Cohen’s d effect size.
Results
Demographic data
The clinical characteristics of the sample of 265 BPD pa-
tients (239 women, 90.8% and 26 men, 9.8%) are shown
in Table 1. The median number of positive criteria in
the SCID-II was 7 (min = 5; max = 9). Ages ranged from
18 to 58, with a mean of 32 years old (SD = 8.9). The
mean number of years of education was 14 (SD = 2.5).
Subjects were predominantly single (N = 186; 70.2%) and
without children (N = 194; 73.2%). The educational level
can be described as low (9–11 years) for 19.2% (N =
51), medium (12–14 years) for 38.5% (N = 102), and
high (≥15 years) for 42.3% (N = 112) of the sample.
More than half of the sample (N = 149; 56.2%) were
neither studying nor working at the time of the study.
Since no gender differences were found for all mea-
sures, the analyses were computed for the entire sam-
ple (men and women).
Psychometric properties of the French BSL-23
Reliability
The original BSL-23 [15, 16] was tested on different
samples of BPD patients and showed very good internal
consistency (N = 379; Cronbach’s alpha = .97; N= 147;
Cronbach’s alpha = .94; N = 35; Cronbach’s alpha = .96).
In our sample (N = 265), the global Cronbach’s alpha
was .94, and with the split-half method the reliability co-
efficient was .93. In the item-by-item reliability analysis,
Cronbach’s alpha coefficients ranged from .936 to .942.
Results indicate that the 23-item scale has high in-
ternal consistency. The BSL-23 mean score of the sample
(N= 265) was 1.90 (SD = .88; min = .22; max = 3.83).
To study the test-retest reliability of the French BSL-
23, a sub-sample of 61 BPD patients were asked to
complete the instrument again after one week. This
revealed a high correlation (r = .841; p < .001) between
the first (m = 1.89; SD = 1.00) and second time (m= 1.73;
SD = .91) the scale was completed, which suggests high
test-retest reliability. In the original study, Bohus et al.
[16] already found high test-retest reliability (r = .82;
p < .001) in a sample of 35 subjects.
Factor structure
The KMO measure of our data’s sampling adequacy was
very high (.936) and Bartlett’s test of sphericity (3263.2)
was highly significant (p < .001). Both measures indicated
that the factor analysis is appropriate for our data. The
factor analysis of the original BSL-23 [15, 16] suggested
a one-factor structure, and both the principal compo-
nent analysis and the scree plot of eigenvalues supported
the dominance of a single factor, accounting for 40.6% of
the total variance. In our data, the single factor ex-
plained 44.7% of variance. Although the EFA showed
four factors with eigenvalues greater than 1.0 (10.285,
1.445, 1.201 and 1.131), cumulatively accounting for
61.1% of the variance, the scree plot (Fig. 1) indicated a
one-factor solution. Retaining all factors with eigen-
values greater than 1.0 is often an overestimation of the
number of factors to be retained and Floyd and Wida-
man [34] suggest that the scree plot is a more useful
guide. Another factor analysis was therefore conducted,
specifying that a single factor should be identified. When
one factor was fixed, all items showed factorial loadings
equal or superior to .40, which is an acceptable level for
a central factor (Table 2).
The goodness of fit test was good (chi square = 765.25,
df = 230, p < .001), but results of the CFA with the one-
factor and recommended fit indexes were less than
satisfactory. The values of RMSEA (.114) and RMSR
(.116) were above .10, which is usually considered to be
unacceptable. The CFI (.82) and the GFI (.78) were
inferior to .90 indicating a poor fit. Models with 2, 3 or
4 factors were examined but they didn’t provide for a
better fit. The inadequacy of fit of our basic CFA model
could be explained by the fact that several items, namely
items 5, 7, 11, 12, 21, and 23, were highly inter-
correlated (≥.70) (Table 3).
Convergent validity
The following scales were used to analyse the convergent
validity of the French BSL-23: BDI-II, BHS, BIS-10 and
STAXI. All correlations are reported in Table 4. Because
of the large number of correlations calculated from this
sample, we applied the Bonferroni correction and fo-
cused on correlations that were significant at p ≤ .005.
As found in previous reports [15, 16], the French BSL-
23 score was highly correlated with depression severity,
as measured by the BDI-II (r = .550), and with hopeless-
ness, as measured by the BHS (r = .350). In addition,
high scores on the BSL-23 were associated with state-
anger (r = .482), trait-anger (r = .285), anger-in (r = .284)
and anger-out (r = .194) subscales of the STAXI. Correla-
tions between BSL-23 and motor impulsivity (sub-score
of the BSI; r = .281) were also found. A positive correl-
ation (rs = .200, n = 265, p = .001) was found between
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number of positive criteria at the SCID-II and severity of
symptoms in BSL-23.
Discriminant validity
To determine whether the French BSL-23 discriminates
BPD patients from other patient groups, the question-
naire was given to 45 patients (18 women, 40% and 27
men, 60%) with ADHD and no comorbid BPD. The
demographic characteristics of the two groups showed
no statistically significant differences. Independent
sample tests (t = 8.084, p < .001) showed that BPD pa-
tients had higher BSL-23 scores compared with ADHD
patients (m = .78; SD = .49). This result support the fact
that the items of the BSL-23 were selected because of
their ability to discriminate between BPD patients and
patients with different axis I diagnoses [15, 16].
Sensitivity to change
We examined changes in the French BSL-23 scores in a
sample of 92 BPD patients (87 women and 5 men) who
participated in a four-week I-DBT. Patients completed
the BSL-23 before and after the four-week program.
BSL-23 scores decreased significantly after I-DBT
(before: 2.00; SD = .91; after: 1.53; SD = .86) with a
medium effect size (d = .53).
Discussion
The aim of this study was to investigate the psychometric
properties of a French version of the BSL-23 in a BPD
sample. Our results showed that its psychometric proper-
ties were similar to those of the original [15, 16] and the
Spanish [18] versions. The French BSL-23 had a high in-
ternal consistency and test-retest reliability and the factor
analysis showed one highly dominant factor. The French
version of the BSL-23 was correlated with depression
(BDI-II), hopelessness (BHS), experience and expression
of anger (STAXI), and impulsivity (BIS-10); the strongest
correlation was found to be with depression severity
(r = .550). Bohus et al. [16] already found moderate-
to-high correlations between the BSL-23 and depres-
sion, as well as general severity of psychopathology
and global well-being. This was supported in the
study by Soler et al. [18], showing that the Spanish
version of the BSL-23 positively correlated with measures
of depression and anxiety symptoms, hostility, and impul-
sivity. The correlation with depression was also among the
strongest ones in their study. BPD has a great comorbidity
with depression [35] and there are similarities between de-
pressive symptoms assessed by the BDI-II and BSL-23
items assessing suicidal ideations and dysphoria which are
diagnosis criteria of BPD. The correlation between BSL-23
and hopelessness (BHS) was also expected as depressed
BPD patients tend to exhibit high levels of hopelessness
[36]. Associations with impulsivity (BIS-10) and anger
(STAXI) measures show that the BSL-23 captures a wide
range of BPD symptoms, including emotional and behav-
ioral dysregulations. The positive correlation between se-
verity of symptomatology measured by the BSL-23 and
Fig. 1 Scree plot of French BSL-23
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number of positive criteria at the SCID-II (BPD part) also
supports this idea.
In our study, we also demonstrated the discriminant
validity of the French BSL-23 when comparing BPD
patients with ADHD patients. Although these two
disorders are highly comorbid and share similar charac-
teristics, such as impulsiveness and emotion dysregula-
tion [37], the French BSL-23 was able to discriminate
between the two conditions, a fact that demonstrates the
specificity of the scale in assessing BPD symptomatology.
This is consistent with the findings of Bohus et al. [16],
showing the ability of the original version of the BSL-23
to distinguish between patients suffering from various
psychiatric disorders, including ADHD, and patients
suffering from BPD.
Besides being useful in assessing the disorder’s current
severity, we found that the French version of the BSL-23
was sensitive to change after a four-week I-DBT
intervention. Again, this is consistent with the results of
previous studies showing that the original version of the
BSL-23, as well as its Spanish version, had a good
sensitivity to change either after 12 weeks of specific
treatment for BPD or after a three-month DBT therapy,
respectively [16, 18]. Further studies could investigate
the relevance of this instrument to measure changes in
borderline symptomatology after a longer psychothera-
peutic intervention targeting BPD patients specifically,
such as standard DBT [17] or Mentalization-Based
Treatment [38].
Some limitations must be considered. First, the
BSL-23 is a self-report measure and is obviously
dependent on the introspective ability of the person.
Nonetheless, the positive correlation between BSL-23
mean score and number of symptoms assessed by
the SCID-II suggests that patients’ own evaluation
was coherent with the clinician’s assessment of BPD.
Another limitation should be reported with regard to
the ADHD patients included in our study. They were
clinically assessed to exclude a BPD diagnosis by
expert psychiatrists, but they didn’t undergo the
BPD interview of the SCID-II to confirm the absence
of BPD.
Table 2 Factor Structure of the French BSL-23
BSL items Factor 1
BSL-1 It was hard for me to concentrate - Il m’était difficile de me concentrer .483
BSL-2 I felt helpless - J’étais désespéré(e) .787
BSL-3 I was absent-minded and unable to remember what I was actually doing -
J’avais l’esprit ailleurs et j’étais incapable de me rappeler ce que j’étais en train de faire
.479
BSL-4 I felt disgust - Je me suis senti(e) dégouté(e) .691
BSL-5 I thought of hurting myself - J’ai pensé à me faire du mal .727
BSL-6 I didn’t trust other people - Je n’avais pas confiance aux autres .399
BSL-7 I didn’t believe in my right to live - Je ne croyais pas en mon droit de vivre .763
BSL-8 I was lonely - J’étais seul(e) .425
BSL-9 I experienced stressful inner tension - J’ai vécu une tension interne stressante .640
BSL-10 I had images that I was very much afraid of - J’avais des images qui me faisaient peur .598
BSL-11 I hated myself - Je me détestais .799
BSL-12 I wanted to punish myself - Je voulais me punir .797
BSL-13 I suffered from shame - J’ai éprouvé de la honte .682
BSL-14 My mood rapidly cycled in terms of anxiety, anger, and depression -
Mon humeur changeait rapidement passant de l’anxiété, à la colère et à la tristesse
.682
BSL-15 I suffered from voices and noises from inside and/or outside my head -
J’ai entendu des voix et des bruits provenant de l’intérieur ou de l’extérieur de ma tête
.399
BSL-16 Criticism had a devastating effect on me - Les critiques d’autrui ont eu un effet dévastateur sur moi .703
BSL-17 I felt vulnerable - Je me suis senti(e) vulnérable .689
BSL-18 The idea of death had a certain fascination for me - L’idée de la mort m’a fasciné(e) .631
BSL-19 Everything seemed senseless to me - Tout me paraissait vide de sens .727
BSL-20 I was afraid of losing control - J’avais peur de perdre le contrôle .691
BSL-21 I felt disgusted by myself - Je me suis senti(e) dégoûté(e) de moi-même .823
BSL-22 I felt as if I was far away from myself - Je me suis senti(e) comme très éloigné(e) de moi-même .700
BSL-23 I felt worthless - Je me suis senti(e) sans valeur .778
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Conclusions
BPD is the most common personality disorder in clinical
settings, but, to our knowledge, no self-report instruments
in French was available to assess the severity of the disorder
and its sensitivity to change following a therapeutic inter-
vention. Our study showed that the French BSL-23 has
good psychometric properties, provides a specific assess-
ment of BPD symptomatology and is sensitive to change.
This study provides a tool in French that is both easy and
quick to use. It will allow clinicians and researchers to
effectively measure borderline symptomatology.
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16 0.36 0.49 0.38 0.49 0.36 0.28 0.49 0.29 0.44 0.39 0.47 0.44 0.46 0.55 0.28 1.00
17 0.27 0.49 0.26 0.38 0.46 0.32 0.47 0.31 0.41 0.45 0.44 0.43 0.39 0.48 0.18 0.54 1.00
18 0.14 0.42 0.17 0.35 0.59 0.17 0.61 0.30 0.35 0.36 0.44 0.53 0.32 0.32 0.37 0.34 0.37 1.00
19 0.22 0.51 0.30 0.46 0.50 0.22 0.52 0.41 0.49 0.35 0.53 0.50 0.41 0.52 0.31 0.50 0.49 0.48 1.00
20 0.27 0.49 0.32 0.41 0.42 0.30 0.41 0.25 0.50 0.47 0.51 0.49 0.50 0.50 0.21 0.45 0.55 0.31 0.46 1.00
21 0.35 0.60 0.36 0.61 0.58 0.23 0.57 0.27 0.40 0.38 0.76 0.71 0.63 0.48 0.30 0.54 0.50 0.45 0.54 0.56 1.00
22 0.26 0.47 0.41 0.46 0.36 0.28 0.41 0.24 0.43 0.42 0.51 0.50 0.44 0.45 0.37 0.48 0.51 0.36 0.55 0.60 0.58 1.00
23 0.42 0.66 0.31 0.51 0.49 0.29 0.57 0.28 0.39 0.29 0.67 0.58 0.49 0.41 0.24 0.51 0.56 0.38 0.52 0.44 0.72 0.58 1.00
aItems with a level of correlation equal or above .70 are bold
Table 4 Correlations between French BSL-23 and other
dimensions
scale scores Na BSL-23
BDI-II 245 .550*
BHS 245 .350*
BIS-10—Motor impulsivity 190 .281*
BIS-10—Cognitive impulsivity 190 .196
BIS-10—Non-planning impulsivity 190 .063
BIS-10—Total 190 .241*
STAXI—State Anger 220 .482*
STAXI—Trait Anger 220 .285*
STAXI—Anger-in 220 .284*
STAXI—Anger-out 220 .194*
STAXI—Anger Control 220 .341*
aN vary because of missing data
*Correlation significant at p ≤ .005
BDI-II Beck Depression Inventory II, BHS Beck Hopelessness Scale, BIS-10 Barrat
Impulsivity Scale, STAXI State-Trait Anger Expression Inventory
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